"Market Intelligence that Adds Flavour to Your Success"

Bovine Collagen Market Size, Share & Industry Analysis, By Product Type (Hydrolyzed Collagen / Collagen Peptides, Native Collagen, Undenatured Collagen, and Others), By Source (Bovine Hide / Skin, Bovine Bone, Bovine Cartilage, and Others), By Form (Powder, Liquid, and Others), By Grade (Food & Nutraceutical Grade, Pharmaceutical & Medical Grade, Cosmetic Grade, and Others), By Application (Dietary Supplements & Nutraceuticals, Food & Beverages, Pharmaceuticals, Medical & Healthcare, Cosmetics & Personal Care, and Others), and Regional Forecast, 2026-2034

Last Updated: November 16, 2026 | Format: PDF | Report ID: FBI119726

 

Buy Now

(Offer valid till 30th Nov 2026)

Bovine Collagen Market Size and Future Outlook

Play Audio Listen to Audio Version

The global bovine collagen market size was valued at USD 1.29 billion in 2025. The market is projected to grow from USD 1.41 billion in 2026 to USD 2.75 billion by 2034, exhibiting a CAGR of 8.71% during the forecast period.

Bovine collagen comprises collagen proteins, peptides, and functional collagen materials obtained primarily from cattle hides, bones, cartilage, and other collagen-rich bovine tissues. The market includes hydrolyzed collagen or collagen peptides, native collagen, and undenatured collagen used in dietary supplements, functional foods, pharmaceuticals, wound-care products, regenerative medicine, medical devices, cosmetics, and personal care formulations.

The global market is primarily driven by the rising consumption of collagen-based nutraceuticals, functional foods, dietary supplements, and beauty-from-within products. Growing awareness of joint health, bone strength, skin elasticity, muscle recovery, and healthy aging is increasing the use of bovine collagen peptides across sports nutrition and wellness formulations. Moreover, growing geriatric population and rising incidence of musculoskeletal conditions are further supporting demand for collagen-based mobility and joint-health products.

GELITA AG, Rousselot B.V., Nitta Gelatin Inc., PB Leiner, and Nippi, Incorporated are among the prominent participants operating in the global market. Competition increasingly centers on access to traceable cattle-derived raw materials, hydrolysis technology, molecular-weight control, protein purity, neutral taste and odor, solubility, medical-grade purification, source certification, scientific substantiation, and the ability to develop collagen ingredients for specific functional outcomes.

Targeted Peptide Innovation and Traceable Bovine Sourcing are Shifting Collagen Toward Specialized Functional Applications

Bovine collagen suppliers are increasingly differentiating their portfolios based on peptide functionality, molecular-weight distribution, source certification, and intended health benefits or end-use applications rather than competing only on protein content. Conventional hydrolyzed collagen continues to account for the majority of market volume, while suppliers are expanding their portfolios with specialized collagen formulations designed for beauty, sports recovery, joint health, metabolic health, healthy ageing, and medical nutrition applications. This shift is expanding demand for low-dose peptides, agglomerated powders, fast-dissolving formulations, grass-fed materials, and products with halal or kosher certification and documented source traceability. Gelatine Manufacturers of Europe explains that hydrolysis conditions can be adjusted to obtain peptides with different molecular-weight distributions and characteristics. The resulting liquid hydrolysate is then spray-dried to produce powder.

  • For instance, in June 2026, Darling Ingredients' Rousselot received United States Patent No. US12636339 covering the production and dietary-supplement use of its Nextida GC collagen peptide composition for post-meal glucose management.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Expanding Cattle Processing is Strengthening Raw-Material Availability for Value-Added Collagen Ingredients, Driving Market Growth

Bovine collagen production benefits from established cattle-rearing and meat-processing value chains. Hides, bones, and cartilage are generated as by-products from slaughter and meat processing; converting suitable fractions into collagen ingredients adds commercial value to suitable meat-processing by-products. Scaling collagen-peptide production requires sufficient demand and reliable collection, segregation, preservation, and processing of collagen-rich tissues. Gelatine Manufacturers of Europe describes collagen and gelatine manufacturing as part of a circular-economy model in which meat-industry by-products are upgraded into protein products. The upstream cattle base remains substantial base for raw material.

  • For instance, the United States Department of Agriculture Foreign Agricultural Service reports global beef production of approximately 61.78 million metric tons in 2024/25 and 62.25 million metric tons in 2025/26. Brazil accounts for approximately 12.61 million metric tons in 2025/26, followed by the U.S., China, the European Union, and India among the largest producers.

Market Drivers - Impact & CAGR Contribution (2026–2034)

Rank Market Drivers Expected Impact on Market Growth CAGR Contribution / Impact, 2026–2034 Impact: 2026-2028 Impact: 2029-2031 Impact: 2032-2034
1 Expansion of collagen-peptide consumption in dietary supplements, sports nutrition and healthy-ageing formulations High 3.25% High High High
2 Commercial valorization of bovine hides, bones and other cattle-processing by-products High 2.77% Medium High High
3 Rising use of bovine collagen in beauty-from-within and cosmetic applications High 2.29% Medium High High
4 Rising use of bovine collagen in beauty-from-within and cosmetic applications Medium 1.81% Medium Medium High
5 Demand for traceable, grass-fed, halal, kosher and source-certified bovine collagen Medium 1.33% Medium High High
6 Others – Low-molecular-weight peptide design, agglomeration, formulation improvement and clinical substantiation Low 0.77% Low Low Low
Total Gross Growth Contribution 12.22%  

Source: Fortune Business Insights

Download Free sample For In-Depth Market Restraints & Risk Analysis

MARKET RESTRAINTS

Traceability Requirements and Fluctuating Cattle Supply to Restrain Product Adoption

Bovine-derived raw materials are subject to sourcing, traceability, and safety requirements. Collagen manufacturers must verify animal origin and slaughterhouse eligibility and control collection conditions, microbiological quality, and traceability. For pharmaceutical and medical applications, risks associated with transmissible agents. Supplier changes cannot always be made quickly because pharmaceutical, medical-device, and premium nutraceutical customers frequently qualify individual raw-material sources and production processes. In Europe, bovine-derived pharmaceutical collagen peptides face additional documentation requirements, including controls associated with the European Directorate for the Quality of Medicines & HealthCare. Regional cattle-supply fluctuations may place pressure on raw-material sourcing.

  • According to the United States Department of Agriculture National Agricultural Statistics Service reported 86.7 million head of cattle and calves in the U.S. as of January 1, 2025, down 1% from a year earlier.

Market Restraints - Impact & Negative CAGR Contribution (2026–2034)

Rank Market Restraints Expected Impact on Market Growth Estimated Reduction in Market CAGR
(2026-2034)
Impact: 2026-2028 Impact: 2029-2031 Impact: 2032-2034
1 Animal-origin traceability, transmissible-disease controls, medical qualification and regulatory compliance High -1.59% High High Medium-High
2 Volatility in cattle slaughter, bovine hide/bone availability and raw-material procurement cost Medium-High -1.11% High Medium-High Medium
3 Competition from marine, porcine, poultry, recombinant and alternative protein ingredients Medium -0.63% Medium-High Medium Medium
4 Others – Energy and water intensity, sensory constraints, quality rejection and supply-chain disruptions Low -0.18% Low Low Low
Total Market Reduction -3.51%  

Source: Fortune Business Insights

Download Free sample For In-Depth Market Restraints & Risk Analysis

MARKET OPPORTUNITIES

Healthy Ageing and Regenerative Medicine are Creating Higher-Value Uses Beyond Conventional Supplement Powders

Bovine collagen market growth is expected to be supported by applications that require specific material properties or functional performance beyond general protein supplementation. Ageing populations are increasing commercial interest in mobility, connective-tissue support, skin ageing, wound management, rehabilitation, and regenerative medicine. This demographic shift does not itself establish clinical efficacy for collagen, but it may expand the potential user population for healthy-ageing products and, where clinically appropriate, medical technologies using collagen as a structural biomaterial.

  • For instance, the World Health Organization estimated that the global population aged 60 years and above will rise to 1.4 billion by 2030 and 2.1 billion by 2050, while one in six people worldwide is expected to be aged 60 or older by 2030.

Segmentation Analysis

By Product Type

Hydrolyzed Collagen / Collagen Peptides Dominated Owing to Its Solubility and Netural Gelling Behaviour

Based on product type, the market is segmented into hydrolyzed collagen/collagen peptides, native collagen, undenatured collagen, and others.

The hydrolyzed collagen/collagen peptides segment dominated the market with a valuation of approximately USD 1.09 billion in 2025. Hydrolysis breaks native collagen into shorter peptide chains, producing an ingredient that dissolves readily, has limited gelling behavior, and can be incorporated into powdered supplements, gummies, protein bars, beverages, beauty formulations, and clinical-nutrition products with fewer of the processing limitations associated with intact collagen. The segment is also projected to record the highest CAGR of approximately 8.90% during 2026-2034, supported by continued product development in nutraceutical and functional-health applications.

The undenatured collagen segment is expected to grow second-fastest at a CAGR of approximately 8.40% over the forecast period, supported particularly by joint and cartilage-focused formulations where maintaining specific protein structures has commercial relevance.

To know how our report can help streamline your business, Speak to Analyst

By Source

High Type-I Collagen Yield and Established Hide-Processing Capacity Supported the Dominance of Bovine Hide / Skin

Based on source, the bovine collagen market is segmented into bovine hide/skin, bovine bone, bovine cartilage, and others.

Bovine hide/skin accounted for the largest share, valued at approximately USD 0.79 billion in 2025. Hide-derived material benefits from the scale of global meat and leather-processing chains, a comparatively high concentration of Type-I collagen, and well-established pretreatment, extraction, hydrolysis, purification, and drying technologies.

Bovine bone accounted for second-largest share valued at approximately USD 0.30 billion in 2025 and remains vital where ossein and bone-derived collagen streams are integrated with gelatine production.

Bovine cartilage is projected to grow at the fastest CAGR of approximately 9.79% during 2026-2034 as cartilage-associated collagen materials are being utilized in joint-health, orthopedic, tissue-repair, and specialized medical applications.

By Form

Long Shelf Life, High Active Loading, and Ease of Blending Makes Powder the Most Preferred Form

Based on form, the market is divided into powder, liquid, and others.

The powder segment dominated the global market valued at approximately USD 1.07 billion in 2025. Powder is the preferred format as it offers comparatively high protein concentration, efficient storage and transportation, easier dosage control, and compatibility with tubs, sachets, sticks, capsules, tablets, premixes, protein bars, gummies, and dry functional-food systems. It also allows ingredient suppliers to serve both bulk industrial customers and consumer-product manufacturers from the same production platform. Powder is projected to record the highest CAGR of approximately 8.94% during 2026-2034.

The liquid segment forms the second-highest growth tier at approximately 7.90% CAGR over the forecast period, supported by ready-to-drink nutrition, liquid supplements, shots, and specialized clinical formulations where pre-solubilized collagen offers formulation convenience.

By Grade

High-Volume Supplement and Functional-Food Formulation Keeps Food & Nutraceutical Grade at the Center of Demand

Based on grade, the market is segmented into food & nutraceutical grade, pharmaceutical & medical grade, cosmetic grade, and others.

Food & nutraceutical grade dominated with approximately USD 0.96 billion in 2025, reflecting the much larger consumption volumes associated with dietary supplements, protein powders, functional beverages, gummies, bars, fortified foods, and beauty-from-within products. Food-grade collagen peptides can be manufactured as highly soluble, non-gelling powders and integrated into finished formulations at gram-level serving sizes, producing considerably greater physical demand than specialized medical collagen.

Pharmaceutical & medical grade is projected to record the fastest CAGR of approximately 9.84% during 2026-2034, supported by wound care, regenerative medicine, tissue engineering, drug-delivery systems, and medical-device applications.

By Application

Habitual Supplement Use and Multi-Benefit Wellness Positioning Keep Dietary Supplements & Nutraceuticals in Leading Position

Based on application, the market is segmented into dietary supplements & nutraceuticals, food & beverages, pharmaceuticals, medical & healthcare, cosmetics & personal care, and others.

Dietary supplements & nutraceuticals dominated the market with approximately USD 0.63 billion in 2025. Bovine collagen fits naturally into powdered supplements as manufacturers can offer gram-level servings in flavored or unflavored formats while positioning products across protein supplementation, active ageing, sports recovery, beauty-from-within, joint-health, and general wellness categories. Powder, capsule, gummy, stick-pack, and functional-drink formats have widened the number of consumption occasions available to ingredient suppliers.

Medical & healthcare is projected to register the fastest CAGR at approximately 10.31% during 2026-2034, supported by wound dressings, collagen matrices, collagen-based scaffolds, and regenerative applications.

Bovine Collagen Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

North America

North America Bovine Collagen Market Size, 2025 (USD Billion)

To get more information on the regional analysis of this market, Download Free sample


North America dominated the global bovine collagen market share and was valued at approximately USD 0.40 billion in 2025 and is projected to reach about USD 0.81 billion by 2034, registering a CAGR of 8.22% during 2026-2034. The region combines a mature dietary-supplement industry, established sports-nutrition consumption, widespread use of powdered protein products, demand for beauty-from-within products, and a substantial medical-device and regenerative-biomaterials industry. Collagen suppliers can therefore address several price tiers, ranging from bulk hydrolyzed powders to clinically positioned bioactive peptides and medical-grade collagen matrices.

U.S. Bovine Collagen Market

The U.S. market was valued at approximately USD 0.30 billion in 2025, making it the largest market in North America. Demand is supported by sports-nutrition brands, supplement manufacturers, contract formulators, functional-food companies, beauty brands, pharmaceutical customers, and medical-device producers.

Europe

Europe accounted for approximately USD 0.35 billion in 2025 and is projected to reach around USD 0.68 billion by 2034, exhibiting a CAGR of 7.46% during 2026-2034. Europe has a long-established gelatine and collagen-processing industry and a substantial base of food, nutraceutical, pharmaceutical, and cosmetic customers. The region also places considerable emphasis on traceability, veterinary controls, microbiological specifications, and documentation of bovine raw-material origin.

Germany Bovine Collagen Market

Germany represented approximately USD 0.10 billion in 2025, making it the largest European market. Country has a mature nutritional-supplement base with significant ingredient-processing expertise and pharmaceutical and medical demand. Germany is also the headquarters market of GELITA, whose global collagen operations are coordinated from Eberbach.

Asia Pacific

Asia Pacific reached approximately USD 0.33 billion in 2025 and is projected to reach around USD 0.79 billion by 2034, registering the fastest CAGR of approximately 10.17% during 2026-2034. Growth is being supported by increasing supplement consumption, beauty-oriented nutrition, sports and fitness products, local collagen manufacturing, rising incomes, and broader access through digital commerce and pharmacy channels. The region also has major bovine-material supply and processing bases in India and China alongside sophisticated functional-food and collagen industries in Japan.

China Bovine Collagen Market

China's market was estimated at approximately USD 0.11 billion in 2025, making it the largest in Asia Pacific. Demand spans across beauty supplements, functional foods, traditional e-commerce channels, cross-border nutrition brands, domestic ingredient manufacturers, and medical biomaterials.

India Bovine Collagen Market

India accounted for approximately USD 0.05 billion in 2025 and is projected to grow at a CAGR of approximately 11.97% during 2026-2034, the highest growth rate among Asia Pacific. India combines expanding domestic nutraceutical demand with a bovine-bone processing base and increasing export-oriented collagen capacity.

South America and Middle East & Africa

South America was valued at approximately USD 0.13 billion in 2025 and is projected to reach around USD 0.28 billion by 2034, recording a CAGR of 8.98% during 2026-2034. Brazil's large cattle-processing industry gives the region strategic importance as a hub for raw-material and collagen manufacturing. South American collagen production is therefore supported by proximity to bovine hide, bone, and related by-products, while regional demand is expanding through dietary supplements, functional nutrition, beauty products, and exports.

The Middle East & Africa market was valued at approximately USD 0.08 billion in 2025 and is projected to reach approximately USD 0.18 billion by 2034, registering a CAGR of around 9.52% during 2026-2034. Growth is supported by nutritional-supplement adoption, sports nutrition, healthcare spending, and demand for halal-compatible bovine proteins. Source verification is particularly significant in the region, giving certified halal and fully traceable bovine collagen an advantage in certain customer groups.

Brazil Bovine Collagen Market

Brazil's market was valued at approximately USD 0.08 billion in 2025. Country’s large cattle herd and meat-processing infrastructure provide a substantial base for hides, bones, and other collagen-containing tissues for valorization. Brazil has a well-established collagen and gelatine production base, with domestic manufacturing facilities serving local demand as well as export markets. The country is projected to expand at approximately 8.98% CAGR during 2026-2034.

COMPETITIVE LANDSCAPE

Key Industry Players

Clinical Evidence, Source Traceability, and Peptide Specialization to Create Differentiation Amongst Suppliers in Their Product Portfolios

The global bovine collagen market includes multinational gelatine and collagen manufacturers, specialized peptide companies, medical-biomaterial producers, and vertically integrated processors using hides, bones, cartilage, and other bovine tissues. GELITA AG, Rousselot B.V., Nitta Gelatin Inc., PB Leiner, and Nippi, Incorporated are among the prominent participants.

Large suppliers benefit from the ability to secure raw material across several production regions, maintain quality systems appropriate to their food and pharmaceutical product lines, and produce collagen ingredients with different specifications. Suppliers differentiate their offerings through molecular-weight control, dispersibility, low odor, source transparency, agglomeration, medical-grade purity, clinical documentation, and application support. PB Leiner, for example, offers collagen peptides from bovine, porcine, and fish sources together with certified grass-fed bovine options.

LIST OF KEY BOVINE COLLAGEN COMPANIES PROFILED

  • GELITA AG (Germany)
  • Darling Ingredients Inc. (Netherlands)
  • Nitta Gelatin Inc. (Japan)
  • PB Leiner (Belgium)
  • Nippi, Incorporated (Japan)
  • Jellice Co., Ltd. (Japan)
  • Lapi Gelatine S.p.A. (Italy)
  • Italgel S.p.A. (Italy)
  • Regenity Biosciences (U.S.)
  • SYMATESE SAS (France)

KEY INDUSTRY DEVELOPMENTS

  • September 2026: PB Leiner announced new peer-reviewed work examining the early-phase absorption characteristics of its SOLUGEL Supra ultra-low-molecular-weight collagen peptide formulation, reflecting the industry's increasing focus on peptide composition rather than generic hydrolyzed protein.
  • April 2026: Regenity Biosciences announced a new Allendale, New Jersey campus intended to consolidate operations, supply chain, packaging, research and development, and corporate functions as the company expands its collagen-based regenerative-device platform.
  • December 2025: Darling Ingredients and Tessenderlo Group signed definitive agreements to combine the Rousselot and PB Leiner collagen and gelatine businesses. The proposed company would have approximately USD 1.5 billion in annual revenue and around 200,000 metric tons of annual gelatine and collagen capacity across 22 facilities.
  • April 2025: GELITA reported a new randomized, double-blind, placebo-controlled study involving bovine-derived VERISOL collagen peptides, with reported improvements in skin hydration, elasticity, and wrinkle-related parameters.
  • April 2024: Nitta Gelatin announced an expansion of collagen-peptide production capacity in India from 600 tonnes per year to 1,150 tonnes per year, with the additional capacity originally scheduled to begin operations in June 2025.

REPORT COVERAGE

The bovine collagen market report provides a detailed assessment of all market segments, highlighting the key drivers, trends, opportunities, restraints, and challenges influencing industry growth. It also examines advancements in collagen extraction, hydrolysis, peptide fractionation, and drying technologies; trends in bovine hide and bone sourcing; raw-material traceability and quality requirements, regulatory and safety considerations related to animal-derived ingredients, major industry developments, market share analysis, and comprehensive profiles of leading bovine collagen manufacturers and suppliers.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

ATTRIBUTE  DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 8.71%% from 2026 to 2034
Unit Value (USD Billion)
Segmentation By Product Type, Source, Form, Grade, Application, and Region
By Product Type
  • Hydrolyzed Collagen / Collagen Peptides
  • Native Collagen
  • Undenatured Collagen
  • Others
By Source
  • Bovine Hide / Skin
  • Bovine Bone
  • Bovine Cartilage
  • Others
By Form
  • Powder
  • Liquid
  • Others
By Grade
  • Food & Nutraceutical Grade
  • Pharmaceutical & Medical Grade
  • Cosmetic Grade
  • Others
By Application
  • Dietary Supplements & Nutraceuticals
  • Food & Beverages
  • Pharmaceuticals
  • Medical & Healthcare
  • Cosmetics & Personal Care
  • Others
By Region
  • North America  (By Product Type, Source, Form, Grade, Application, and Country)
    • U.S. (By Product Type, Source, Form, Grade, Application)
    • Canada (By Product Type, Source, Form, Grade, Application)
    • Mexico (By Product Type, Source, Form, Grade, Application)
  • Europe (By Product Type, Source, Form, Grade, Application, and Country)
    • Germany (By Product Type, Source, Form, Grade, Application)
    • U.K. (By Product Type, Source, Form, Grade, Application)
    • France (By Product Type, Source, Form, Grade, Application)
    • Spain (By Product Type, Source, Form, Grade, Application)
    • Italy (By Product Type, Source, Form, Grade, Application)
    • Rest of Europe (By Product Type, Source, Form, Grade, Application)
  • Asia Pacific (By Product Type, Source, Form, Grade, Application, and Country)
    • China (By Product Type, Source, Form, Grade, Application)
    • Japan (By Product Type, Source, Form, Grade, Application)
    • India (By Product Type, Source, Form, Grade, Application)
    • Australia (By Product Type, Source, Form, Grade, Application)
    • Southeast Asia (By Product Type, Source, Form, Grade, Application)
    • Rest of Asia Pacific (By Product Type, Source, Form, Grade, Application)
  • South America (By Product Type, Source, Form, Grade, Application, and Country)
    • Brazil (By Product Type, Source, Form, Grade, Application)
    • Argentina (By Product Type, Source, Form, Grade, Application)
    • Rest of South America (By Product Type, Source, Form, Grade, Application)
  • Middle East & Africa (By Product Type, Source, Form, Grade, Application, and Country)
    • GCC (By Product Type, Source, Form, Grade, Application)
    • South Africa (By Product Type, Source, Form, Grade, Application)
    • Rest of Middle East & Africa (By Product Type, Source, Form, Grade, Application)

Research Methodology

1. Bottom-Up Approaches

Approach 1: Revenues and Bovine Collagen Sales of Major Manufacturers

  • Collect collagen-specific revenue, production volumes, plant capacities, product portfolios, geographic sales, and source information for GELITA, Rousselot, Nitta Gelatin, PB Leiner, Nippi, Jellice, Lapi Gelatine, Italgel, Regenity Biosciences, and other relevant suppliers.
  • Remove revenue attributable to porcine collagen, marine collagen, poultry collagen, conventional gelatine, collagen casings, unrelated proteins, rendered products, and finished consumer brands where ingredient revenue cannot be isolated.
  • Map manufacturer revenues across hydrolyzed collagen/collagen peptides, native collagen, undenatured collagen, and others.
  • Further allocate revenue among bovine hide/skin, bovine bone, bovine cartilage, and other bovine sources.
  • Reconcile powder, liquid, grade, and end-use exposure using product catalogs, technical specifications, certifications, and customer applications.
  • Estimate private-company bovine collagen sales using stated plant capacity, product mix, utilization, source mix, bulk pricing, geographic footprint, and comparable manufacturer benchmarks.
  • Allocate sales to the market in which collagen is commercially consumed rather than solely to the location in which the ingredient is produced.

Approach 2: Cattle Processing × Recoverable Collagen-Rich Material × Extraction Yield × ASP

  • Use cattle slaughter, beef production, hide generation, bone recovery, and other cattle-processing statistics from national agricultural authorities.
  • Estimate the portion of cattle by-products suitable and available for food, nutraceutical, pharmaceutical, cosmetic, or medical collagen production.
  • Separate hide/skin, bone/ossein, and cartilage because collagen concentration, pretreatment requirements, extraction yields, and final product values differ materially.
  • Apply processing losses and extraction/hydrolysis yields rather than assuming the full mass of hides or bones converts into marketable collagen.
  • Separate hydrolyzed collagen volume from native or undenatured collagen.
  • Develop weighted B2B average selling prices by product type, source, grade, and geography.
  • Calculate: Eligible Bovine Raw Material × Collagen Recovery × Commercial Yield × Utilization × Weighted ASP.
  • Reconcile the resulting value with reported manufacturer capacity and end-use demand to prevent overestimation.

Approach 3: End-Use Consumption and Formulation Requirement

  • Estimate collagen ingredient consumption independently for dietary supplements, functional food & beverages, pharmaceuticals, medical/healthcare, and cosmetics/personal care.
  • For supplements, use addressable users × collagen-product penetration × average daily dose × annual consumption × ingredient ASP.
  • For functional foods and beverages, estimate collagen-containing product output × inclusion rate × manufacturer ingredient price.
  • For medical applications, triangulate wound dressings, matrices, implants, regenerative products, and other bovine-collagen devices using unit volume, collagen content, and supplier realization.
  • Adjust for formulation waste, inventory changes, distributor margins, and repeated resale to avoid double counting.
  • Cross-check total modeled consumption against upstream manufacturer and raw-material estimates.

2. Top-Down Approaches

Approach 1: Global Collagen / Gelatine Supply Chain and Bovine-Origin Allocation

  • Establish the global commercial collagen and gelatine supply base using company capacities, official industry associations, animal-processing data, and trade statistics.
  • Remove conventional gelatine that is outside the defined collagen market.
  • Allocate collagen output by animal origin—bovine, porcine, marine/fish, poultry, and others—using manufacturer portfolios, production-site disclosures, certifications, and raw-material availability.
  • Divide the bovine component into hydrolyzed/collagen peptides, native collagen, undenatured collagen, and other defined products.
  • Allocate value across food & nutraceutical, pharmaceutical & medical, cosmetic, and other grades.
  • Distribute global demand among North America, Europe, Asia Pacific, South America, and Middle East & Africa using supplement consumption, cattle-processing presence, manufacturing capacity, medical use, consumer income, functional-food penetration, and local pricing.
  • Reconcile the resulting top-down estimate against company-derived sales and physical raw-material calculations.

3. List of Key Sources

  • Food and Agriculture Organization of the United Nations
  • United States Department of Agriculture Foreign Agricultural Service
  • United States Department of Agriculture National Agricultural Statistics Service
  • United States Food and Drug Administration
  • World Health Organization
  • Gelatine Manufacturers of Europe
  • European Directorate for the Quality of Medicines & HealthCare
  • European Commission
  • Eurostat
  • National veterinary and cattle-slaughter authorities
  • National customs authorities
  • United Nations Comtrade
  • Company annual reports
  • Investor presentations
  • Manufacturing-capacity disclosures
  • Product catalogs and technical specifications
  • Regulatory filings and medical-device clearances
  • Company press releases and corporate announcements

4. Primary Interviews

Supply-Side Interviews: 60%

  • Key Respondents: Bovine collagen manufacturers, collagen-peptide processors, gelatine manufacturers, cattle processors, slaughterhouses, hide processors, bone/ossein processors, cartilage suppliers, nutraceutical-ingredient distributors, medical-grade biomaterial manufacturers, pharmaceutical suppliers, quality managers, formulation scientists, sourcing managers, contract manufacturers, certification bodies, and industry associations.
  • Discussions should cover raw-material origin, hide/bone/cartilage procurement, extraction yield, hydrolysis yield, molecular-weight specifications, powder versus liquid mix, native versus hydrolyzed collagen, plant capacity, utilization rates, grade mix, food versus medical quality requirements, bulk average selling prices, customer concentration, source certification, halal and kosher requirements, grass-fed claims, traceability, microbiological specifications, transmissible spongiform encephalopathy controls, distribution margins, exports, regional demand, and expected capacity additions.

Demand-Side Interviews: 40%

  • Key Respondents: Dietary-supplement brands, sports-nutrition companies, functional-food and beverage manufacturers, gummy manufacturers, contract supplement manufacturers, pharmaceutical companies, wound-care companies, regenerative-medicine developers, medical-device manufacturers, cosmetic brands, personal-care companies, distributors, pharmacies, health retailers, and specialist e-commerce platforms.
  • Interviews should assess collagen inclusion rates, preferred source, daily dosage, molecular-weight requirements, powder versus liquid usage, grade requirements, purchasing volumes, source-certification preferences, price sensitivity, grass-fed and halal demand, beauty-from-within positioning, sports and active-ageing applications, medical qualification requirements, supplier-switching barriers, formulation issues, branded versus generic peptides, and expected changes in bovine collagen consumption through 2034.


Frequently Asked Questions

Fortune Business Insights says that the global market value stood at USD 1.29 billion in 2025 and is projected to reach USD 2.75 billion by 2034.

In 2025, the market value in North America stood at USD 0.40 billion.

The market is expected to grow at a CAGR of 8.71% over the forecast period.

The hydrolyzed collagen/collagen peptides segment led the market by product type.

Expanding cattle processing is strengthening raw-material availability for value-added collagen ingredients.

GELITA AG, Rousselot B.V., Nitta Gelatin Inc., PB Leiner, and Nippi are among the prominent players in the market.

North America dominated the market in 2025.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 200
  • Buy Now

    (Offer valid till 30th Nov 2026)

Download Free Sample

    man icon
    Mail icon
    Mail icon
Jump to Content

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Food & Beverages Clients
Sumitomo
Daesang
Ferrero
Fuji film
Agthia Group PJSC
Ajinomoto
Barclays
Brooks International
DSM
Koch Industries, Inc.
Korn Ferry
McCain
Mitsubishi Corporation
Nestle
Nissin Foods
Samyang Foods
Singapore Food Agency
Starbucks
The Kraft Heinz Company
Yum Brands